Here is a comprehensive interpretation guide for HbA1c, drawn from authoritative sources:
HbA1c Interpretation
What Is HbA1c?
HbA1c (glycated or glycosylated hemoglobin) is formed by the nonenzymatic attachment of glucose to the N-terminal valine of the beta chain of hemoglobin. Its concentration depends on blood glucose levels and erythrocyte lifespan. Since the average red cell lives ~120 days, HbA1c reflects average blood glucose over the preceding 8–12 weeks.
Importantly, recent glucose levels carry disproportionate weight: the last 30 days contribute ~50% of the HbA1c value, while glucose from 90–120 days prior contributes only ~10%.
— Textbook of Family Medicine 9e
Diagnostic Thresholds (ADA/WHO Criteria)
| Category | HbA1c (NGSP/%) | HbA1c (IFCC mmol/mol) |
|---|
| Normal | < 5.7% | < 39 mmol/mol |
| Prediabetes | 5.7–6.4% | 39–47 mmol/mol |
| Diabetes | ≥ 6.5% | ≥ 48 mmol/mol |
- In the absence of unequivocal hyperglycemia, diagnosis requires two abnormal results from the same or separate samples.
- In patients with classic symptoms, a random glucose ≥ 200 mg/dL is sufficient without repeating the assay.
— Tietz Textbook of Laboratory Medicine, 7th Edition
Monitoring & Treatment Goals
| Target | HbA1c |
|---|
| General diabetes control goal | < 7.0% |
| Tighter control (select patients) | < 6.5% |
| Relaxed target (elderly, comorbidities) | < 8.0% |
HbA1c is used to:
- Diagnose diabetes
- Monitor glycemic control
- Evaluate need to change therapy
- Predict development of microvascular complications (retinopathy, nephropathy, neuropathy)
Converting HbA1c to Estimated Average Glucose (eAG)
$$\text{eAG (mg/dL)} = (28.7 \times \text{HbA1c%}) - 46.7$$
| HbA1c (%) | eAG (mg/dL) | eAG (mmol/L) |
|---|
| 5.0 | 97 | 5.4 |
| 6.0 | 126 | 7.0 |
| 6.5 | 140 | 7.8 |
| 7.0 | 154 | 8.6 |
| 8.0 | 183 | 10.2 |
| 9.0 | 212 | 11.8 |
| 10.0 | 240 | 13.4 |
— Quick Compendium of Clinical Pathology, 5th Ed.
Reporting Units
- NGSP/DCCT/UKPDS system: reported as % — most widely used clinically
- IFCC system: reported as mmol/mol
- Conversion: 7% (NGSP) = 53 mmol/mol (IFCC)
Factors That Give FALSELY LOW HbA1c
| Condition | Mechanism |
|---|
| Hemolytic anemia | Shortened RBC lifespan → less time for glycation |
| Acute/significant blood loss | Higher proportion of young RBCs |
| Hemoglobin variants (HbS, HbC, HbF) | Method-dependent interference |
| Splenomegaly, hypersplenism | Accelerated RBC destruction |
Factors That Give FALSELY HIGH HbA1c
| Condition | Mechanism |
|---|
| Iron deficiency anemia | Increased glycation (mechanism uncertain) |
| Renal failure (older assays) | Carbamylated hemoglobin interferes |
| Hyperlipidemia, certain medications | Method-dependent |
Other Caveats
- Race: Black, Asian, and Latino individuals have systematically higher HbA1c (~0.2–0.3% higher in Black patients) without necessarily having worse glycemia. Clinical significance remains debated.
- Renal failure: Uremic toxins interfere with some assays; interpret with caution in dialysis patients.
- Pregnancy: HbA1c is less reliable due to altered RBC turnover; plasma glucose criteria are preferred for gestational diabetes screening.
— Tietz Textbook of Laboratory Medicine, 7th Ed.; Textbook of Family Medicine 9e
Best Measurement Methods
| Method | Notes |
|---|
| HPLC (ion exchange) | Gold standard; detects Hb variants |
| Boronate affinity chromatography | Minimally affected by Hb variants |
| Immunoassay | Widely used in POC/automated analyzers |
| Capillary electrophoresis | Can flag Hb variants visually |
For patients with hemoglobin variants, boronate affinity chromatography or a method certified by NGSP for that variant should be used. (See
www.NGSP.org for method-specific interference data.)